Evanson Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-9,050
| Closed | -$298K | – | 269 |
|
|
2020
Q3 | $298K | Hold |
9,050
| – | – | 0.05% | 183 |
|
|
2020
Q2 | $248K | Sell |
9,050
-5,000
| -36% | -$137K | 0.05% | 199 |
|
|
2020
Q1 | $421K | Sell |
14,050
-920
| -6% | -$27.6K | 0.1% | 122 |
|
|
2019
Q4 | $414K | Sell |
14,970
-5,755
| -28% | -$159K | 0.08% | 146 |
|
|
2019
Q3 | $377K | Hold |
20,725
| – | – | 0.08% | 151 |
|
|
2019
Q2 | $508K | Hold |
20,725
| – | – | 0.1% | 115 |
|
|
2019
Q1 | $197K | Hold |
20,725
| – | – | 0.04% | 227 |
|
|
2018
Q4 | $183K | Hold |
20,725
| – | – | 0.04% | 214 |
|
|
2018
Q3 | $233K | Hold |
20,725
| – | – | 0.05% | 213 |
|
|
2018
Q2 | $265K | Hold |
20,725
| – | – | 0.05% | 206 |
|
|
2018
Q1 | $350K | Buy |
20,725
+6,675
| +48% | +$113K | 0.07% | 171 |
|
|
2017
Q4 | $112K | Hold |
14,050
| – | – | 0.02% | 242 |
|
|
2017
Q3 | $109K | Buy |
+14,050
| New | +$109K | 0.02% | 228 |
|